Hepatocellular Carcinoma Clinical Trials

2169 clinical trials for Hepatocellular Carcinoma across international registries, including 397 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours — RECRUITING · PHASE1
• the Effect of Nutrition-optimized Prehabilitation on Perioperative Intervention in Primary Liver Carcinoma — RECRUITING · NA
• 68Ga-SorB PET/CT Imaging in Patients With Solid Tumors — RECRUITING · NA
• A Study of MGC026 in Participants With Advanced Solid Tumors — RECRUITING · PHASE1
• STRIDE (Durvalumab + Tremelimumab) With Lenvatinib vs STRIDE Alone in Unresectable Hepatocellular Carcinoma — RECRUITING · PHASE2
• HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer — RECRUITING · NA
• Molecular Basis of Pediatric Liver Cancer — RECRUITING
• The Safety, Efficacy, and Immune Response of Multimodal Thermal Therapy in the Treatment of Malignant Liver Tumors — RECRUITING · NA
• Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors — RECRUITING · PHASE1
• IDOV-Immune for Advanced Solid Tumors — RECRUITING · PHASE1
• The Safety and Efficacy of Ondansetron in Reducing Immune Checkpoint Inhibitor-Related Toxicities — RECRUITING · PHASE2
• Radiotherapy Combined With QL1706 and Bevacizumab for Unresectable Non-metastatic Hepatocellular Carcinoma — RECRUITING · PHASE2
• TARGETed Therapy Drug MONITOring in DIGestive Oncology — RECRUITING · NA
• On-treatment Surveillance of Tumor Evolution and Response to Systemic Treatment in Bile Duct and Liver Cancer — RECRUITING
• Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC — RECRUITING · PHASE2
• TITAN-HCC: Neoadjuvant and Adjuvant QL1706 With TACE in Resectable Hepatocellular Carcinoma Beyond Milan Criteria — RECRUITING · NA
• A Phase 1 Study of the Safety and Tolerability of CTX-10726 — RECRUITING · PHASE1
• The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas — RECRUITING · PHASE2
• MRG006A Combination Therapy for Advanced Hepatocellular Carcinoma (Phase I/II) — RECRUITING · PHASE1
• Atezolizumab and Bevacizumab in Combination With Y^90 Radioembolization in HCC for Liver Transplant — RECRUITING · PHASE4
• MONTEROSA - Italian Multicenter Observational Study to Evaluate Time to Clinical Hepatic Decompensation, Quality of Life, Effectiveness, and Safety of Tremelimumab Plus Durvalumab in Patients With Advanced or Unresectable Hepatocellular Carcinoma Who Have Received no Prior Systemic Treatment. — RECRUITING
• A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206) — RECRUITING · PHASE1
• Identification of Innovative Biomarkers to Predict Outcomes in Hepatocellular Carcinoma Treated With Tremelimumab and Durvalumab — RECRUITING · NA
• Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body. — RECRUITING · PHASE1
• A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors — RECRUITING · PHASE1
• To Evaluate Safety and Efficacy of FB-1603 in Hepatocellular Carcinoma Patient Receiving Transarterial Chemoembolization — RECRUITING · PHASE1
• A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer — RECRUITING · PHASE1
• AD HOC Trial: Artificial Intelligence-Based Drug Dosing In Hepatocellular Carcinoma — RECRUITING · PHASE2
• Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma — RECRUITING · PHASE3
• Survival and Recurrence After ABO-Incompatible Living Donor Liver Transplantation for Hepatocellular Carcinoma — RECRUITING
• Multi-analyte Blood Test Clinical Trial — RECRUITING
• A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer — RECRUITING
• An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer — RECRUITING
• ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma — RECRUITING · PHASE1
• Targeted Navigation in Hepatocellular Carcinoma (HCC) — RECRUITING · NA
• CEUS vs. AMRI for HCC Detection in Patients With Indeterminate Liver Nodules — RECRUITING · NA
• Project for Multi-Omics-Based Early Detection of Hepatocellular Carcinoma (PROMETHEA Study) — RECRUITING
• Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma — RECRUITING · PHASE2
• GPC3-Targeted PET/CT in Hepatocellular Carcinoma — RECRUITING · NA
• Deep, Multi-omics Phenotyping to Predict Response, Resistance and Recurrence to Adjuvant Atezolizumab Plus Bevacizumab in Resected Hepatocellular Carcinoma — RECRUITING · PHASE2
• PSMA PET for the Staging and Management of Hepatocellular Carcinoma — RECRUITING
• Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies — RECRUITING · PHASE2
• TACE and/or HAIC Combined With Molecular-targeted Therapy and Immunotherapy for HCC — RECRUITING
• A Phase I, First in Human Study of CBA-1205, Anti-DLK1 Monoclonal Antibody in Patients With Advanced Solid Tumors, Hepatocellular Carcinoma (HCC), Melanoma, and Pediatric Cancer — RECRUITING · PHASE1
• mSEPT9 Biomarker for Predicting Hepatocellular Carcinoma Occurrence in Patients With Cirrhosis — RECRUITING
• Y-90 Treatment Response Using Transarterial Radioembolization — RECRUITING · PHASE2
• A Trial Utilizing 18F-FS PG PET to Guide Therapy in Hepatocellular Carcinoma — RECRUITING · PHASE1
• Lenalidomide Plus Targeted Therapy and Immunotherapy for Refractory HCC — RECRUITING · PHASE2
• Construction and Clinical Validation of a Predictive Model for Postoperative Adjuvant Therapy in Hepatocellular Carcinoma Based on Whole-Slide Digital Pathological Images and Deep Learning — RECRUITING · NA
• Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program — RECRUITING · PHASE2

Refine this search